Back to Search Start Over

A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research.

Authors :
Carragee EJ
Baker RM
Benzel EC
Bigos SJ
Cheng I
Corbin TP
Deyo RA
Hurwitz EL
Jarvik JG
Kang JD
Lurie JD
Mroz TE
Oner FC
Peul WC
Rainville J
Ratliff JK
Rihn JA
Rothman DJ
Schoene ML
Spengler DM
Weiner BK
Source :
The spine journal : official journal of the North American Spine Society [Spine J] 2012 Oct; Vol. 12 (10), pp. 877-80.
Publication Year :
2012

Subjects

Subjects :
Clinical Trials as Topic
Guidelines as Topic
Humans
Off-Label Use
Recombinant Proteins adverse effects
Bone Morphogenetic Protein 2 adverse effects
Postoperative Complications etiology
Spinal Fusion adverse effects
Transforming Growth Factor beta adverse effects

Details

Language :
English
ISSN :
1878-1632
Volume :
12
Issue :
10
Database :
MEDLINE
Journal :
The spine journal : official journal of the North American Spine Society
Publication Type :
Editorial & Opinion
Accession number :
23199819
Full Text :
https://doi.org/10.1016/j.spinee.2012.11.002
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details